arrow_back Back to App

Naloxone Affordability Act: Studying Costs and Access to Opioid Overdose Reversal Drug.

This bill aims to improve access to naloxone, a critical medication used to reverse opioid overdoses. It mandates a detailed government study to assess how health insurance plans (private, Medicare, Medicaid) cover over-the-counter naloxone. The goal is to identify steps that can be taken to reduce the out-of-pocket costs for citizens purchasing this life-saving drug.
Key points
Requires a federal study on the coverage and consumer costs of naloxone (opioid overdose reversal medication).
The study will analyze how private insurance, Medicare, and Medicaid cover over-the-counter naloxone.
The objective is to protect access and reduce the purchase cost of naloxone for individuals.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_1373
Sponsor: Sen. Markey, Edward J. [D-MA]
Process start date: 2023-04-27